We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

DNA Methylation and the Cancer Epigenome Biological and Translations Implications

Video   Jan 01, 2014

 

About the Speaker

Stephen B. Baylin, M.D., is deputy director of The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and the Virginia and D.K. Ludwig professor of oncology and medicine. He is chief of the Cancer Biology Division and associate director for research of the center.


Abstract

Genome-wide mapping studies are dramatically contributing to remarkable increases in our understanding of epigenetic abnormalities in cancer.  Abnormal DNA methylation, both losses and gains, and key associated chromatin changes may largely affect  distinct  genomic  regions which contain nuclear lamin associated,  late replicating DNA , enriched for  low transcription, developmental, genes  with promoter region, “bivalent” chromatin .  Such chromatin, in embryonic and adult stem cells, is essential for maintenance of the stem cell state.  Furthermore, in multiple tumor types, frequent mutations are being found in genes which control normal epigenomes.  While the phenotypic consequences of these largely remain to be dissected, mutations in the IDH1 and 2 genes, and in the Tet family of proteins which trigger steps for active DNA de-methylation, are now linked to DNA methylation and chromatin alterations associated with abnormal gene silencing.  Importantly, multiple of the above epigenetic abnormalities are being found in cancer-risk states which involve chronic inflammation and attendant increases in reactive oxygen species (ROS).  Finally, all of the above biology has exciting translational implications for the concepts of “epigenetic therapy” for cancer and molecular signatures which can guide such treatments and also be useful for cancer diagnosis and staging.

 
 
 
Advertisement
 

Recommended Videos

Teach Me in 10 – Understanding COVID-19 Through "Omics" With Dr Clare Paterson

Video

In a COVID-19 special of Teach Me in 10, we're joined by Dr Clare Paterson, senior clinical R&D scientist at SomaLogic, who is currently working on using "omics" approaches to understand the biology of SARS-CoV-2.

WATCH NOW


Stem cell biology: EVOS™ M5000 microscope at the cutting edge research

Video

Quickly check that staining has worked or the reporter line is expressing the protein of interest.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE